By www.reliablemarketsize.com
Global And United States Bio Similars/Subsequent Entry Biologic Market Report & Forecast 2023-2028 Story
119
$ 4350
Bio Similars/Subsequent Entry Biologic Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Sun Pharma Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Biogen idec Genentech (Roche) Pfizer Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG AbbVie Sanofi-Aventis Johnson & Johnson Novo Nordisk Eli Lilly Novartis 3sbio Biotech Gelgen Innovent Dong Bao Ganlee